Monday, December 23, 2024

Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities

Global professional services firm ZS has been selected by leading biopharmaceutical company Bristol Myers Squibb to support its worldwide commercial analytics organization. This agreement builds on and expands the existing, successful partnership that BMS and ZS created in 2015.

Also Read: BCool, the First Battery-Free, Mercury-Free, Eco-Friendly Connected Thermometer is Named a CES 2022 Innovation Awards Honoree

“We look forward to continuing to serve BMS. It is an honor to help one of the most innovative biopharmaceutical companies in the world transform its analytics capabilities and drive business impact.” said Jaideep Bajaj, chairman of ZS.

The work will support BMS’s Business Insights & Analytics (BIA) group—a global, centralized organization that helps drive business success for all markets and business units across BMS through the appropriate use of data. The scope encompasses areas such as data science, marketing mix, forecasting, business development and brand analytics for more than 65 markets.

“For more than 30 years, BMS and ZS have worked together to solve business challenges and deliver organization-wide impact,” said Rohan Fernando, ZS’s client service lead for BMS. “We are thrilled to continue that partnership and help Bristol Myers innovate and drive fact-based decision-making that ultimately helps improve patient outcomes.”

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 10,000-plus ZSers in more than 25 offices worldwide, we are passionately committed to helping companies and their customers thrive.

Subscribe Now

    Hot Topics